|
A Hollywood Party, and You?re Invited (New York Times)
Laurence Mark and Bill Condon are out not so much to produce the Academy Awards ceremony as to find it again. January 2, 2009 (Arts Journal)
In today's Wall Street Journal drama column I review two Irish plays, one in Chicago (Steppenwolf's production of Conor McPherson's The Seafarer ) and one off Broadway (the Atlantic Theater Company's revival of Martin McDonagh's The Cripple of Inishmaan ). Both are superlative. Here's an excerpt. January 5, 2009 (Arts Journal)
About... Terry's latest book, Pops: The Life of Louis Armstrong , will be published by Harcourt in the fall of 2009. One of his essays is included in Robert Gottlieb's Reading Dance , just out from Pantheon. January 5, 2009 (Arts Journal)
DECEMBER 31 Mrs. T and I loaded our car late in the afternoon and drove through a slippery snowstorm from rural Connecticut to LaGuardia Airport, where we holed up in a just-adequate hotel. We were still quivering with retrospective anxiety as we fell into our rock-hard beds. January 2, 2009 (Arts Journal)
I have a piece in the current issue of Commentary called "My Favorite Classical Recordings." It's an annotated list of twenty-five recordings made between 1926 and 1973 that I regard as indispensable: Love that lobster (The Buffalo News)
In Spain, they may be eating grapes for luck as 2008 turns into 2009. In Poland, eat herring. In the southern part of the United States, black eyed peas are the food of choice. Holiday postcard has made rounds for 75 years (Texarkana Gazette)
AUSTIN-In 1933, a former silent movie piano player from Bridgeton, N.J., picked out a Christmas card to send to her brother in Atlantic City. North Hampton town employees keep operations running through storm (Hampton Union)
NORTH HAMPTON and#8212; Long-serving town employees kept the town running smoothly and safely during the recent ice storm and blackout. Maryland-based Profectus BioSciences wins $21.6M in NIH contracts (TechJournal South)
BALTIMORE, MD - Profectus BioSciences Inc., a biopharmaceutical company that develops proprietary prime/boost vaccines and small molecules to treat and prevent viral infections and cancers, has received two contracts from the National Institute of Allergy and Infectious Diseases totaling $21.6 million. Profectus BioSciences Awarded $21.6 Million In NIH Contracts To Develop A HIV Preventative And A HIV Therapeutic Vaccine (Medical News Today)
Profectus BioSciences, Inc.
|